nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinitapride—HTR2A—epilepsy syndrome	0.618	1	CbGaD
Cinitapride—HTR2A—phrenic nerve—epilepsy syndrome	0.0256	0.18	CbGeAlD
Cinitapride—HTR4—telencephalon—epilepsy syndrome	0.012	0.0839	CbGeAlD
Cinitapride—HTR2A—locus ceruleus—epilepsy syndrome	0.0115	0.0803	CbGeAlD
Cinitapride—HTR2A—cerebellar cortex—epilepsy syndrome	0.00934	0.0654	CbGeAlD
Cinitapride—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00911	0.0639	CbGeAlD
Cinitapride—HTR2A—vagus nerve—epilepsy syndrome	0.00877	0.0615	CbGeAlD
Cinitapride—HTR2A—pons—epilepsy syndrome	0.0066	0.0463	CbGeAlD
Cinitapride—HTR2A—autonomic nervous system—epilepsy syndrome	0.00609	0.0427	CbGeAlD
Cinitapride—HTR1A—ganglion—epilepsy syndrome	0.00567	0.0398	CbGeAlD
Cinitapride—HTR2A—telencephalic ventricle—epilepsy syndrome	0.00543	0.0381	CbGeAlD
Cinitapride—HTR4—brain—epilepsy syndrome	0.0054	0.0379	CbGeAlD
Cinitapride—HTR1A—hindbrain—epilepsy syndrome	0.0043	0.0302	CbGeAlD
Cinitapride—HTR2A—ganglion—epilepsy syndrome	0.00338	0.0237	CbGeAlD
Cinitapride—HTR2A—hindbrain—epilepsy syndrome	0.00256	0.018	CbGeAlD
Cinitapride—HTR1A—brainstem—epilepsy syndrome	0.00247	0.0173	CbGeAlD
Cinitapride—HTR1A—forebrain—epilepsy syndrome	0.00238	0.0167	CbGeAlD
Cinitapride—HTR1A—telencephalon—epilepsy syndrome	0.00219	0.0153	CbGeAlD
Cinitapride—HTR1A—midbrain—epilepsy syndrome	0.00157	0.011	CbGeAlD
Cinitapride—HTR1A—spinal cord—epilepsy syndrome	0.00153	0.0107	CbGeAlD
Cinitapride—HTR2A—brainstem—epilepsy syndrome	0.00147	0.0103	CbGeAlD
Cinitapride—HTR2A—forebrain—epilepsy syndrome	0.00142	0.00994	CbGeAlD
Cinitapride—HTR1A—head—epilepsy syndrome	0.00136	0.00955	CbGeAlD
Cinitapride—HTR2A—telencephalon—epilepsy syndrome	0.0013	0.00914	CbGeAlD
Cinitapride—HTR1A—nervous system—epilepsy syndrome	0.00129	0.00906	CbGeAlD
Cinitapride—HTR1A—central nervous system—epilepsy syndrome	0.00124	0.00872	CbGeAlD
Cinitapride—HTR1A—cerebellum—epilepsy syndrome	0.00122	0.00852	CbGeAlD
Cinitapride—HTR2A—medulla oblongata—epilepsy syndrome	0.00102	0.00718	CbGeAlD
Cinitapride—HTR1A—brain—epilepsy syndrome	0.000987	0.00692	CbGeAlD
Cinitapride—HTR2A—midbrain—epilepsy syndrome	0.000937	0.00656	CbGeAlD
Cinitapride—HTR2A—spinal cord—epilepsy syndrome	0.000914	0.0064	CbGeAlD
Cinitapride—HTR2A—head—epilepsy syndrome	0.000812	0.00569	CbGeAlD
Cinitapride—HTR2A—nervous system—epilepsy syndrome	0.00077	0.0054	CbGeAlD
Cinitapride—HTR2A—central nervous system—epilepsy syndrome	0.000741	0.0052	CbGeAlD
Cinitapride—HTR2A—cerebellum—epilepsy syndrome	0.000725	0.00508	CbGeAlD
Cinitapride—HTR2A—brain—epilepsy syndrome	0.000589	0.00412	CbGeAlD
Cinitapride—HTR4—Signaling Pathways—IL6ST—epilepsy syndrome	4.78e-05	0.0002	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CNR1—epilepsy syndrome	4.75e-05	0.000199	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CCR3—epilepsy syndrome	4.75e-05	0.000199	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PLCB1—epilepsy syndrome	4.74e-05	0.000198	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—AGT—epilepsy syndrome	4.71e-05	0.000197	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GRM8—epilepsy syndrome	4.69e-05	0.000196	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PGF—epilepsy syndrome	4.69e-05	0.000196	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—SST—epilepsy syndrome	4.68e-05	0.000196	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CCR2—epilepsy syndrome	4.68e-05	0.000196	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—HTR7—epilepsy syndrome	4.64e-05	0.000194	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—NPY—epilepsy syndrome	4.63e-05	0.000194	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—POMC—epilepsy syndrome	4.59e-05	0.000192	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—ADRA2A—epilepsy syndrome	4.58e-05	0.000192	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SSTR3—epilepsy syndrome	4.55e-05	0.00019	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—CCL2—epilepsy syndrome	4.49e-05	0.000188	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GNAO1—epilepsy syndrome	4.47e-05	0.000187	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—OPRD1—epilepsy syndrome	4.47e-05	0.000187	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—OXT—epilepsy syndrome	4.47e-05	0.000187	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CRH—epilepsy syndrome	4.47e-05	0.000187	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CXCL2—epilepsy syndrome	4.47e-05	0.000187	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CCL3—epilepsy syndrome	4.47e-05	0.000187	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—SST—epilepsy syndrome	4.45e-05	0.000186	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CCR2—epilepsy syndrome	4.45e-05	0.000186	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ST3GAL3—epilepsy syndrome	4.45e-05	0.000186	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—AKT3—epilepsy syndrome	4.42e-05	0.000185	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CXCL12—epilepsy syndrome	4.4e-05	0.000184	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—BDKRB2—epilepsy syndrome	4.4e-05	0.000184	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—POMC—epilepsy syndrome	4.37e-05	0.000183	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ARHGEF9—epilepsy syndrome	4.36e-05	0.000182	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SSTR1—epilepsy syndrome	4.36e-05	0.000182	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCR8—epilepsy syndrome	4.36e-05	0.000182	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCR9—epilepsy syndrome	4.36e-05	0.000182	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NPY2R—epilepsy syndrome	4.36e-05	0.000182	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—ADRA2A—epilepsy syndrome	4.36e-05	0.000182	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CNR1—epilepsy syndrome	4.32e-05	0.000181	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PLCB1—epilepsy syndrome	4.3e-05	0.00018	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CHRM1—epilepsy syndrome	4.29e-05	0.000179	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PDYN—epilepsy syndrome	4.29e-05	0.000179	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCR7—epilepsy syndrome	4.29e-05	0.000179	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GRM1—epilepsy syndrome	4.29e-05	0.000179	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CCL2—epilepsy syndrome	4.28e-05	0.000179	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GRM4—epilepsy syndrome	4.27e-05	0.000179	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GRM3—epilepsy syndrome	4.27e-05	0.000179	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—HTR7—epilepsy syndrome	4.21e-05	0.000176	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SSTR2—epilepsy syndrome	4.19e-05	0.000175	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—DUSP4—epilepsy syndrome	4.19e-05	0.000175	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—BDKRB2—epilepsy syndrome	4.18e-05	0.000175	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CXCL12—epilepsy syndrome	4.18e-05	0.000175	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CNR1—epilepsy syndrome	4.11e-05	0.000172	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PLCB1—epilepsy syndrome	4.09e-05	0.000171	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—HBEGF—epilepsy syndrome	4.09e-05	0.000171	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GRM8—epilepsy syndrome	4.05e-05	0.000169	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PGF—epilepsy syndrome	4.05e-05	0.000169	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CCR2—epilepsy syndrome	4.04e-05	0.000169	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—SST—epilepsy syndrome	4.04e-05	0.000169	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CDC42—epilepsy syndrome	4.03e-05	0.000169	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GAL—epilepsy syndrome	4.03e-05	0.000169	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GFAP—epilepsy syndrome	4.03e-05	0.000169	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—AKT3—epilepsy syndrome	4.01e-05	0.000168	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—HTR7—epilepsy syndrome	4.01e-05	0.000168	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GRM5—epilepsy syndrome	3.99e-05	0.000167	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CHRM3—epilepsy syndrome	3.99e-05	0.000167	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CASP2—epilepsy syndrome	3.99e-05	0.000167	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—POMC—epilepsy syndrome	3.97e-05	0.000166	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—ADRA2A—epilepsy syndrome	3.96e-05	0.000165	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—AVP—epilepsy syndrome	3.9e-05	0.000163	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—CCL2—epilepsy syndrome	3.88e-05	0.000162	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—FGF2—epilepsy syndrome	3.87e-05	0.000162	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GNAO1—epilepsy syndrome	3.86e-05	0.000162	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—OPRD1—epilepsy syndrome	3.86e-05	0.000162	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CX3CR1—epilepsy syndrome	3.82e-05	0.00016	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—AKT3—epilepsy syndrome	3.82e-05	0.00016	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CXCL12—epilepsy syndrome	3.8e-05	0.000159	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—BDKRB2—epilepsy syndrome	3.8e-05	0.000159	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CHRM2—epilepsy syndrome	3.75e-05	0.000157	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—BDKRB1—epilepsy syndrome	3.75e-05	0.000157	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CX3CL1—epilepsy syndrome	3.75e-05	0.000157	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CNR1—epilepsy syndrome	3.73e-05	0.000156	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PLCB1—epilepsy syndrome	3.72e-05	0.000155	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CHRM1—epilepsy syndrome	3.71e-05	0.000155	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCR7—epilepsy syndrome	3.71e-05	0.000155	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GRM1—epilepsy syndrome	3.71e-05	0.000155	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PDYN—epilepsy syndrome	3.71e-05	0.000155	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CDC42—epilepsy syndrome	3.66e-05	0.000153	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GABBR1—epilepsy syndrome	3.65e-05	0.000153	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—HTR7—epilepsy syndrome	3.64e-05	0.000152	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—RELA—epilepsy syndrome	3.59e-05	0.00015	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—AVP—epilepsy syndrome	3.55e-05	0.000148	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—HBEGF—epilepsy syndrome	3.53e-05	0.000148	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MTOR—epilepsy syndrome	3.52e-05	0.000147	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HRH3—epilepsy syndrome	3.5e-05	0.000146	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CDC42—epilepsy syndrome	3.48e-05	0.000146	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GAL—epilepsy syndrome	3.48e-05	0.000146	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GFAP—epilepsy syndrome	3.48e-05	0.000146	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—AKT3—epilepsy syndrome	3.47e-05	0.000145	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CASP2—epilepsy syndrome	3.44e-05	0.000144	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GRM5—epilepsy syndrome	3.44e-05	0.000144	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CHRM3—epilepsy syndrome	3.44e-05	0.000144	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—OPRM1—epilepsy syndrome	3.44e-05	0.000144	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—AVP—epilepsy syndrome	3.37e-05	0.000141	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CCR5—epilepsy syndrome	3.32e-05	0.000139	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CX3CR1—epilepsy syndrome	3.3e-05	0.000138	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—AKT1—epilepsy syndrome	3.27e-05	0.000137	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCR3—epilepsy syndrome	3.25e-05	0.000136	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—HTR2A—epilepsy syndrome	3.25e-05	0.000136	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CHRM2—epilepsy syndrome	3.24e-05	0.000135	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—BDKRB1—epilepsy syndrome	3.24e-05	0.000135	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CX3CL1—epilepsy syndrome	3.24e-05	0.000135	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CASP3—epilepsy syndrome	3.24e-05	0.000135	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ATP2A2—epilepsy syndrome	3.17e-05	0.000132	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NPY—epilepsy syndrome	3.17e-05	0.000132	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CDC42—epilepsy syndrome	3.16e-05	0.000132	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GABBR1—epilepsy syndrome	3.15e-05	0.000132	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—JUN—epilepsy syndrome	3.15e-05	0.000132	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—AGT—epilepsy syndrome	3.08e-05	0.000129	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—AVP—epilepsy syndrome	3.06e-05	0.000128	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MMP9—epilepsy syndrome	3.06e-05	0.000128	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCL3—epilepsy syndrome	3.06e-05	0.000128	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—OXT—epilepsy syndrome	3.06e-05	0.000128	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CRH—epilepsy syndrome	3.06e-05	0.000128	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CXCL2—epilepsy syndrome	3.06e-05	0.000128	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HSPB1—epilepsy syndrome	3.06e-05	0.000128	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HRH3—epilepsy syndrome	3.02e-05	0.000126	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CCR5—epilepsy syndrome	3.01e-05	0.000126	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—OPRM1—epilepsy syndrome	2.97e-05	0.000124	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—AKT1—epilepsy syndrome	2.97e-05	0.000124	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—HTR2A—epilepsy syndrome	2.95e-05	0.000123	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CCR5—epilepsy syndrome	2.87e-05	0.00012	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.85e-05	0.000119	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TSC1—epilepsy syndrome	2.84e-05	0.000119	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PTK2B—epilepsy syndrome	2.84e-05	0.000119	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—SRC—epilepsy syndrome	2.82e-05	0.000118	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCR3—epilepsy syndrome	2.81e-05	0.000117	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—AGT—epilepsy syndrome	2.8e-05	0.000117	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SST—epilepsy syndrome	2.76e-05	0.000116	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NTRK2—epilepsy syndrome	2.76e-05	0.000116	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCR2—epilepsy syndrome	2.76e-05	0.000116	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—VEGFA—epilepsy syndrome	2.75e-05	0.000115	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—DUSP6—epilepsy syndrome	2.74e-05	0.000115	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NPY—epilepsy syndrome	2.74e-05	0.000114	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ATP2A2—epilepsy syndrome	2.74e-05	0.000114	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ADRA2A—epilepsy syndrome	2.7e-05	0.000113	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PLAT—epilepsy syndrome	2.69e-05	0.000113	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—AGT—epilepsy syndrome	2.66e-05	0.000111	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HSPB1—epilepsy syndrome	2.64e-05	0.00011	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—OXT—epilepsy syndrome	2.64e-05	0.00011	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CRH—epilepsy syndrome	2.64e-05	0.00011	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCL3—epilepsy syndrome	2.64e-05	0.00011	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CXCL2—epilepsy syndrome	2.64e-05	0.00011	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CCR5—epilepsy syndrome	2.6e-05	0.000109	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CXCL12—epilepsy syndrome	2.6e-05	0.000109	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—BDKRB2—epilepsy syndrome	2.6e-05	0.000109	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—POMC—epilepsy syndrome	2.59e-05	0.000109	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PRKCB—epilepsy syndrome	2.59e-05	0.000108	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—IL6ST—epilepsy syndrome	2.58e-05	0.000108	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—JUNB—epilepsy syndrome	2.55e-05	0.000107	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CNR1—epilepsy syndrome	2.55e-05	0.000107	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PLCB1—epilepsy syndrome	2.54e-05	0.000106	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HTR7—epilepsy syndrome	2.49e-05	0.000104	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.46e-05	0.000103	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PTK2B—epilepsy syndrome	2.45e-05	0.000103	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TSC1—epilepsy syndrome	2.45e-05	0.000103	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—AGT—epilepsy syndrome	2.42e-05	0.000101	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HBEGF—epilepsy syndrome	2.42e-05	0.000101	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCR2—epilepsy syndrome	2.39e-05	9.99e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SST—epilepsy syndrome	2.39e-05	9.99e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NTRK2—epilepsy syndrome	2.39e-05	9.99e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AKT3—epilepsy syndrome	2.37e-05	9.92e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—DUSP6—epilepsy syndrome	2.37e-05	9.9e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—POMC—epilepsy syndrome	2.36e-05	9.86e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ADRA2A—epilepsy syndrome	2.34e-05	9.77e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PLAT—epilepsy syndrome	2.33e-05	9.73e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ADAM10—epilepsy syndrome	2.32e-05	9.69e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CCL2—epilepsy syndrome	2.31e-05	9.64e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—BDKRB2—epilepsy syndrome	2.24e-05	9.39e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CXCL12—epilepsy syndrome	2.24e-05	9.39e-05	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—POMC—epilepsy syndrome	2.24e-05	9.38e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PRKCB—epilepsy syndrome	2.23e-05	9.35e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—IL6ST—epilepsy syndrome	2.23e-05	9.31e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—JUNB—epilepsy syndrome	2.2e-05	9.22e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CNR1—epilepsy syndrome	2.2e-05	9.22e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PLCB1—epilepsy syndrome	2.2e-05	9.18e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—S100B—epilepsy syndrome	2.19e-05	9.16e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SOCS3—epilepsy syndrome	2.17e-05	9.07e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CDC42—epilepsy syndrome	2.16e-05	9.05e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HTR7—epilepsy syndrome	2.15e-05	8.99e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AVP—epilepsy syndrome	2.09e-05	8.76e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HBEGF—epilepsy syndrome	2.09e-05	8.73e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AKT3—epilepsy syndrome	2.05e-05	8.57e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—POMC—epilepsy syndrome	2.04e-05	8.51e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ADAM10—epilepsy syndrome	2e-05	8.37e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CCL2—epilepsy syndrome	1.99e-05	8.33e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HES1—epilepsy syndrome	1.98e-05	8.28e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FYN—epilepsy syndrome	1.93e-05	8.06e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—H2AFX—epilepsy syndrome	1.92e-05	8.03e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MEF2C—epilepsy syndrome	1.92e-05	8.01e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—S100B—epilepsy syndrome	1.89e-05	7.91e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SOCS3—epilepsy syndrome	1.87e-05	7.84e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CDC42—epilepsy syndrome	1.87e-05	7.82e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.85e-05	7.74e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NGF—epilepsy syndrome	1.83e-05	7.66e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AVP—epilepsy syndrome	1.81e-05	7.57e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCR5—epilepsy syndrome	1.78e-05	7.45e-05	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—AKT1—epilepsy syndrome	1.75e-05	7.33e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HTR2A—epilepsy syndrome	1.74e-05	7.29e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HES1—epilepsy syndrome	1.71e-05	7.16e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FYN—epilepsy syndrome	1.66e-05	6.96e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—H2AFX—epilepsy syndrome	1.66e-05	6.93e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	1.66e-05	6.93e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MEF2C—epilepsy syndrome	1.65e-05	6.92e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	1.65e-05	6.92e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	1.62e-05	6.78e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.6e-05	6.69e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	1.59e-05	6.64e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NGF—epilepsy syndrome	1.58e-05	6.62e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	1.54e-05	6.44e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.53e-05	6.39e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.52e-05	6.37e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	1.43e-05	5.98e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	1.43e-05	5.98e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	1.4e-05	5.85e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	1.39e-05	5.82e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	1.37e-05	5.74e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	1.36e-05	5.7e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.32e-05	5.52e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.31e-05	5.5e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	1.23e-05	5.15e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	1.2e-05	5.03e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	1.18e-05	4.92e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	1.14e-05	4.78e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	1.12e-05	4.69e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	1.06e-05	4.45e-05	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.04e-05	4.35e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	1.03e-05	4.31e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	1e-05	4.19e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	9.87e-06	4.13e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	9.74e-06	4.07e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	9.68e-06	4.05e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	9.45e-06	3.95e-05	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	8.99e-06	3.76e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	8.98e-06	3.76e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	8.9e-06	3.72e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	8.74e-06	3.66e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	8.65e-06	3.62e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	8.41e-06	3.52e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	8.16e-06	3.41e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	7.76e-06	3.24e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	7.55e-06	3.16e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	5.58e-06	2.33e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	4.82e-06	2.02e-05	CbGpPWpGaD
